Transkaryotic Therapies Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q ~5 pages Ex-10.1 Tkt Management Bonus Plan
12/34/56
EX-10.40
from 10-K/A ~5 pages Ex-10.40 Amendment to 2002 Stock Incentive Plan
12/34/56
EX-10.39
from 10-K/A ~5 pages Ex-10.39 Amendment to 2001 Non-Officer, Non-Director Employee Stock Incentive Plan
12/34/56
EX-10.38
from 10-K/A ~10 pages Ex-10.38 Amendment to 1993 Long-Term Incentive Plan
12/34/56
EX-10.21
from 10-K/A ~5 pages Ex-10.21 Revised Employment Agreement Dated 2-26-2002
12/34/56
EX-10.18
from 10-K/A ~50 pages Ex-10.18 Executive Nonqualified Excess Plan
12/34/56
EX-10.37
from 10-K 1 page Ex-10.37 Summary Description of Director Compensation
12/34/56
EX-10.36
from 10-K ~5 pages Ex-10.36 Form of Incentive Stock Option Agreement
12/34/56
EX-10.35
from 10-K ~5 pages Ex-10.35 Form of Nonstatuary Stock Option Agreement
12/34/56
EX-10.34
from 10-K ~5 pages Ex-10.34 Tkt Management Bonus Plan, Including Form of Bonus Schedule
12/34/56
EX-10.33
from 10-K 1 page Ex-10.33 Agreement Dated November 5, 2001 Between Neil Kirby and the Registrant
12/34/56
EX-10.1
from 10-Q 45 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Services Agreement Between Lonza Biologics PLC and Transkaryotic Therapies, Inc. Page 1 of 44
12/34/56
EX-10.42
from 10-Q ~50 pages Ex-10.42 Amended License Agreement
12/34/56
EX-10.42
from 10-K 1 page Ex-10.42 Agreement Dated May 1, 2003
12/34/56
EX-10.41
from 10-Q 7 pages Indemnification Agreement
12/34/56
EX-10.40
from 10-Q 7 pages Material contract
12/34/56
EX-10.39
from 10-Q 2 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions
12/34/56
EX-10.38
from 10-Q 9 pages Employment Agreement
12/34/56
EX-10.37
from 10-Q 8 pages Indemnification Agreement
12/34/56
EX-10.36
from 10-Q 10 pages Transkaryotic Therapies, Inc. 2002 Stock Incentive Plan
12/34/56